Difference between revisions of "Team:LMU-TUM Munich"

Line 19: Line 19:
  
 
==<span style="color:#000000">Abstract:</span> <span style="color:#009440">biot</span><span style="color:#3070b3">INK</span> <span style="color:#8d8d8d">- rethINK tissue printing</span>==
 
==<span style="color:#000000">Abstract:</span> <span style="color:#009440">biot</span><span style="color:#3070b3">INK</span> <span style="color:#8d8d8d">- rethINK tissue printing</span>==
Living in an aging society and facing an increasing organ shortage, we have developed a game-changing approach to bioprint tissues for biomedical application. Our interdisciplinary work entails creating a novel bioink that exploits the rapid and specific interaction of biotin and its tetrameric binding protein streptavidin. By employing this affinity, we have engineered cells presenting biotin moieties or biotin binding proteins on their surfaces and recombinant biotinylated proteins as spacer molecules, which both co-polymerize upon contact with streptavidin. Furthermore, we have explored different cellular circuits, which allow us to control pancreatic cell lines, induce tissue vascularization, or install biosafety mechanisms for printed tissues. To deliver these cells, we employ a hijacked 3D printer that enables us to manufacture three-dimensional multi-cellular structures in a user-definable manner. Altogether, we are confident that our system provides the necessary means to advance the SynBio community to the next level – the tissue level.<br>
+
We are living in an aging society that is facing a decreasing supply of donor organs. To confront this pressing issue, w e developed a game-changing approach to
 +
bioprint tissues for biomedical applications. Our interdisciplinary w ork aims to create a unique ink, named biotINK, to revolutionize bioprinting. The printing process
 +
uses a hijacked 3D printer and two components of biotINK to induce an instantaneous polymerization reaction, creating three-dimensional multi-cellular structures in
 +
a user-definable manner. The principle of this tw o-component glue relies on the rapid and specific interaction of biotin and its tetrameric binding protein, avidin. To
 +
employ the high biotin-avidin affinity, w e engineered cells presenting biotin moieties or biotin-binding proteins on their surfaces, as w ell as recombinant matrix proteins,
 +
which both co-polymerize upon printing. Furthermore, w e explored different genetic circuits which allow us to functionalize the bio-synthetic tissue and install
 +
biosafety mechanisms. Altogether, w e are confident that our system provides the necessary means to advance the SynBio community to the next level – the tissue
 +
level.<br>
 
[[File:Muc_Finalsphoto_001.png|center|950px]]
 
[[File:Muc_Finalsphoto_001.png|center|950px]]
 
<html><video width="830" controls><source src="https://static.igem.org/mediawiki/2016/6/64/Muc16_video3.mp4">
 
<html><video width="830" controls><source src="https://static.igem.org/mediawiki/2016/6/64/Muc16_video3.mp4">

Revision as of 17:12, 16 November 2016

  • Team Photo
  • Another Team Photo
  • Another Team Photo
  • Another Team Photo
  • Another Team Photo
  • Another Team Photo
  • Another Team Photo
  • Another Team Photo


2016/11/02: We will update our wiki within the next 10 days. Please do not hesitate to contact us at iGEM2016.Munich@gmail.com.

Abstract: biotINK - rethINK tissue printing

We are living in an aging society that is facing a decreasing supply of donor organs. To confront this pressing issue, w e developed a game-changing approach to bioprint tissues for biomedical applications. Our interdisciplinary w ork aims to create a unique ink, named biotINK, to revolutionize bioprinting. The printing process uses a hijacked 3D printer and two components of biotINK to induce an instantaneous polymerization reaction, creating three-dimensional multi-cellular structures in a user-definable manner. The principle of this tw o-component glue relies on the rapid and specific interaction of biotin and its tetrameric binding protein, avidin. To employ the high biotin-avidin affinity, w e engineered cells presenting biotin moieties or biotin-binding proteins on their surfaces, as w ell as recombinant matrix proteins, which both co-polymerize upon printing. Furthermore, w e explored different genetic circuits which allow us to functionalize the bio-synthetic tissue and install biosafety mechanisms. Altogether, w e are confident that our system provides the necessary means to advance the SynBio community to the next level – the tissue level.

Muc Finalsphoto 001.png

Sponsors


up button Back to top

LMU & TUM Munich

Technische Universität MünchenLudwig-Maximilians-Universität München

United team from Munich's universities

Contact us:

Address

iGEM Team TU-Munich
Emil-Erlenmeyer-Forum 5
85354 Freising, Germany